- Docket Number:
- Issued by:
Guidance Issuing OfficeOffice of Medical Products and Tobacco, Center for Drug Evaluation and ResearchOffice of Medical Products and Tobacco, Center for Devices and Radiological Health
This guidance is intended to be used as a companion document to the guidance Coronary Drug Eluting Stents — Nonclinical and Clinical Studies, which provides recommendations to sponsors or applicants planning to develop, or to submit to FDA, a marketing application for a coronary drug eluting stent (DES). This companion document provides additional and more detailed guidance on some of the recommendations in the Coronary Drug Eluting Stents guidance, including details on premarket approvals (PMAs), investigational device exemptions (IDEs), examples of various tables that may be submitted, and information on labeling a DES.
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2008-D-0180.